Dr. Aseem Malhotra
๐ค SpeakerAppearances Over Time
Podcast Appearances
And the answer is, and well, because, um, our intelligence evolved, not for seeking objective truth, but more about belonging to a tribe, you know, for personal gain, whatever else. So what is, what do we need to break out of that? There are two characteristics in the human being that are most important for you to think outside the box and be willing to change your mind and not being afraid of it.
And the answer is, and well, because, um, our intelligence evolved, not for seeking objective truth, but more about belonging to a tribe, you know, for personal gain, whatever else. So what is, what do we need to break out of that? There are two characteristics in the human being that are most important for you to think outside the box and be willing to change your mind and not being afraid of it.
And the answer is, and well, because, um, our intelligence evolved, not for seeking objective truth, but more about belonging to a tribe, you know, for personal gain, whatever else. So what is, what do we need to break out of that? There are two characteristics in the human being that are most important for you to think outside the box and be willing to change your mind and not being afraid of it.
One is humility. And the other one is curiosity. So ultimately it comes down to character, right? And we've got a system over the years that has become more and more corporatized, right? You have in America, sadly, you know, and I consider this my, honestly, I'm, you know, I consider America my second home.
One is humility. And the other one is curiosity. So ultimately it comes down to character, right? And we've got a system over the years that has become more and more corporatized, right? You have in America, sadly, you know, and I consider this my, honestly, I'm, you know, I consider America my second home.
One is humility. And the other one is curiosity. So ultimately it comes down to character, right? And we've got a system over the years that has become more and more corporatized, right? You have in America, sadly, you know, and I consider this my, honestly, I'm, you know, I consider America my second home.
So I have a lot of love for America and the American people because I have relatives here and I've been here a lot. But you have now the highest healthcare expenditure in the developed world over $4 trillion with the worst health outcomes. Oops. Right. So, so, so what's happened is, you know, because of all of this situation around corporate capture.
So I have a lot of love for America and the American people because I have relatives here and I've been here a lot. But you have now the highest healthcare expenditure in the developed world over $4 trillion with the worst health outcomes. Oops. Right. So, so, so what's happened is, you know, because of all of this situation around corporate capture.
So I have a lot of love for America and the American people because I have relatives here and I've been here a lot. But you have now the highest healthcare expenditure in the developed world over $4 trillion with the worst health outcomes. Oops. Right. So, so, so what's happened is, you know, because of all of this situation around corporate capture.
So, you know, the counter, of course, from a philosophical point of view is that living a life in darkness is, has no meaning. And we need to get people out of this darkness to understand the root of the problem. And then we can then start making solutions.
So, you know, the counter, of course, from a philosophical point of view is that living a life in darkness is, has no meaning. And we need to get people out of this darkness to understand the root of the problem. And then we can then start making solutions.
So, you know, the counter, of course, from a philosophical point of view is that living a life in darkness is, has no meaning. And we need to get people out of this darkness to understand the root of the problem. And then we can then start making solutions.
No, fascinating. And it makes sense. But also interesting is something else that I came across in the last few years, which you'll find fascinating, Mark. And I don't know if you know this. David Diamond, who's a cholesterol researcher, published a paper I can't remember which journal it was in, very recently.
No, fascinating. And it makes sense. But also interesting is something else that I came across in the last few years, which you'll find fascinating, Mark. And I don't know if you know this. David Diamond, who's a cholesterol researcher, published a paper I can't remember which journal it was in, very recently.
No, fascinating. And it makes sense. But also interesting is something else that I came across in the last few years, which you'll find fascinating, Mark. And I don't know if you know this. David Diamond, who's a cholesterol researcher, published a paper I can't remember which journal it was in, very recently.
And they looked at the primary prevention randomized control trials done by, obviously by the drug companies, and secondary prevention trials. And subgroup analysis found, so these are people with statins who either were high risk of a heart attack or had a heart attack. In the patients in the trials that had normal triglycerides and HDL, no benefit at all from statins. Think about that.
And they looked at the primary prevention randomized control trials done by, obviously by the drug companies, and secondary prevention trials. And subgroup analysis found, so these are people with statins who either were high risk of a heart attack or had a heart attack. In the patients in the trials that had normal triglycerides and HDL, no benefit at all from statins. Think about that.
And they looked at the primary prevention randomized control trials done by, obviously by the drug companies, and secondary prevention trials. And subgroup analysis found, so these are people with statins who either were high risk of a heart attack or had a heart attack. In the patients in the trials that had normal triglycerides and HDL, no benefit at all from statins. Think about that.
So if you're triglycerides, urination, we're good. Even people who've had a heart attack, there was no benefit from the statin at all, which fits with what you just said.
So if you're triglycerides, urination, we're good. Even people who've had a heart attack, there was no benefit from the statin at all, which fits with what you just said.